Literature DB >> 10623369

A review of quality of life in Alzheimer's disease. Parts 1 and 2: Issues in assessing disease impact and drug effects.

S P McKenna, L C Doward.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10623369     DOI： 10.2165/00019053-199916040-00009

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  5 in total

1.  A review of quality of life in Alzheimer's disease. Parts 1 and 2: Issues in assessing disease impact and drug effects.

Authors:  M Greer; H Monteban
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

2.  A critical appraisal of the quality of quality-of-life measurements.

Authors:  T M Gill; A R Feinstein
Journal:  JAMA       Date:  1994 Aug 24-31       Impact factor: 56.272

3.  The 44th annual John Stanley Coulter Lecture. Measuring what matters: key rehabilitation outcomes.

Authors:  G G Whiteneck
Journal:  Arch Phys Med Rehabil       Date:  1994-10       Impact factor: 3.966

Review 4.  A review of quality of life in Alzheimer's disease. Part 1: Issues in assessing disease impact.

Authors:  M D Walker; S S Salek; A J Bayer
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

Review 5.  A review of quality of life in Alzheimer's disease. Part 2: Issues in assessing drug effects.

Authors:  S S Salek; M D Walker; A J Bayer
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.